These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38776565)
1. MDS and AML show elevated fractions of CD34-positive blast cell populations with a high anti-apoptotic versus proliferation ratio. Mestrum SGC; Roanalis BYV; de Wit NCJ; Drent RJM; Boonen BT; van Hemert WLW; Hopman AHN; Ramaekers FCS; Leers MPG Leuk Res; 2024 Jul; 142():107520. PubMed ID: 38776565 [TBL] [Abstract][Full Text] [Related]
2. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Parker JE; Mufti GJ; Rasool F; Mijovic A; Devereux S; Pagliuca A Blood; 2000 Dec; 96(12):3932-8. PubMed ID: 11090080 [TBL] [Abstract][Full Text] [Related]
3. Impact of the gating strategy for Ki-67 and Bcl-2 on the determination of proliferation and anti-apoptosis data by flow cytometry in non-malignant bone marrow aspirates and aspirates from patients with myeloid malignancies. Mestrum SGC; Vanblarcum RBY; de Wit NCJ; Drent RJM; Boonen BT; van Hemert WLW; Hopman AHN; Ramaekers FCS; Leers MPG Data Brief; 2023 Aug; 49():109284. PubMed ID: 37409174 [TBL] [Abstract][Full Text] [Related]
4. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes. Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050 [TBL] [Abstract][Full Text] [Related]
5. 'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins. Parker JE; Fishlock KL; Mijovic A; Czepulkowski B; Pagliuca A; Mufti GJ Br J Haematol; 1998 Dec; 103(4):1075-82. PubMed ID: 9886323 [TBL] [Abstract][Full Text] [Related]
6. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia. Kurotaki H; Tsushima Y; Nagai K; Yagihashi S Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673 [TBL] [Abstract][Full Text] [Related]
7. Proliferative and anti-apoptotic fractions in maturing hematopoietic cell lineages and their role in homeostasis of normal bone marrow. Mestrum SGC; Vanblarcum RBY; Drent RJM; Boonen BT; van Hemert WLW; Ramaekers FCS; Hopman AHN; Leers MPG Cytometry A; 2022 Jul; 101(7):552-563. PubMed ID: 35429122 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes. Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968 [TBL] [Abstract][Full Text] [Related]
9. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes. Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991 [TBL] [Abstract][Full Text] [Related]
11. The proliferation index of specific bone marrow cell compartments from myelodysplastic syndromes is associated with the diagnostic and patient outcome. Matarraz S; Teodosio C; Fernandez C; Albors M; Jara-Acevedo M; López A; Gonzalez-Gonzalez M; Gutierrez ML; Flores-Montero J; Cerveró C; Pizarro-Perea M; Paz Garrastazul M; Caballero G; Gutierrez O; Mendez GD; González-Silva M; Laranjeira P; Orfao A PLoS One; 2012; 7(8):e44321. PubMed ID: 22952954 [TBL] [Abstract][Full Text] [Related]
12. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome]. Zhang Z; Xie J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412 [TBL] [Abstract][Full Text] [Related]
13. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells. Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q J Transl Med; 2011 May; 9():71. PubMed ID: 21595920 [TBL] [Abstract][Full Text] [Related]
14. [Study on the Characteristics of cell cycle and proliferation of CD34+ hematopoietic stem cells in myelodysplastic syndromes]. Shi J; Shao ZH; Liu H; Jia HR; Sun J; Bai J; Wu YH; Jing LP; He GS; Cao YR; Wang XL; Tu MF; Hao YS; Yang TY Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):641-4. PubMed ID: 15634564 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival. Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303 [TBL] [Abstract][Full Text] [Related]
16. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry. Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230 [TBL] [Abstract][Full Text] [Related]
17. Increased CD34+CD38 -CD123 + cells in myelodysplastic syndrome displaying malignant features similar to those in AML. Li LJ; Tao JL; Fu R; Wang HQ; Jiang HJ; Yue LZ; Zhang W; Liu H; Shao ZH Int J Hematol; 2014 Jul; 100(1):60-9. PubMed ID: 24846193 [TBL] [Abstract][Full Text] [Related]
18. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis. Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478 [TBL] [Abstract][Full Text] [Related]
19. Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56. Drexler B; Tzankov A; Martinez M; Baerlocher S; Passweg JR; Dirnhofer S; Tsakiris DA; Dirks J Int J Lab Hematol; 2021 Oct; 43(5):1078-1084. PubMed ID: 33709561 [TBL] [Abstract][Full Text] [Related]
20. In leukemic hematopoiesis CD34 antigen does not have the same significance as it does normal hematopoiesis. Del Cañizo MC; Galende J; Mota A; Orfao A; Martinez A; Almeida J; San Miguel JF Leuk Res; 1997 Jul; 21(7):651-6. PubMed ID: 9301686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]